Does South Korea Need A State-Owned Pharma To Stabilize Supply?
This article was originally published in PharmAsia News
Executive Summary
South Korea repeatedly faced drug supply disruptions when dealing with the outbreak of bird flu and new influenza, and when pharma firms refused to produce inexpensive but essential medicines, or drugs for rare diseases, due to low profitability. A local research paper now says the country may need a state-run pharma to ensure stable future supplies of essential medicines.